A first-ever report describes how overall gains against cancer are not benefiting some racial and ethnic groups—and how COVID-19 may be making it worse.

Precision Health member Matthias Kretzler and U-M researchers from Internal Medicine and Computational Medicine and Bioinformatics contributed to this report.

Santhi Ganesh, MD, a presenter at Precision Health’s 2020 Virtual Symposium, has published a paper in Nature Communications that discusses genetic markers for spontaneous coronary artery dissection, which were identified in a genome-wide association study.

A study in Nature shows tumor cells eat up a key amino acid, depriving immune cells of it, which prevents them from fighting off cancer. Senior author Weiping Zou, MD, PhD, Director of the Michigan Center of Excellence for Cancer Immunology and Immunotherapy, has received a $3.2 million grant from the National Cancer Institute to advance this work.

Precision Health member Shobita Parthasarathy, PhD, Professor of Public Policy and Director of the Science, Technology, and Public Policy program, has authored a piece in Nature that factors social realities and inequalities into COVID-19 testing and diagnoses.